What The Fleury Story Actually Hinged On

If Fleury sat on a watchlist instead of in a portfolio, watching the move from the sidelines may feel uncomfortable. For Fleury shareholders, the return from the start of the year was 61.3%, including dividends. That outcome now looks straightforward next to Q2 2026 figures that show higher revenue and a wider net margin, but what could have signalled in early 2026 that aging demographics and AI adoption might support this kind of profitability shift?

Fleury has already moved. See which of 196 high quality undervalued stocks still trade below our estimates.

The Two Fleury Stories Investors Had To Weigh

The shares cost R$15 at the start, and anyone looking at Fleury then had to decide which of two very different stories felt more plausible.

On the optimistic side, the bullish narrative argued that aging demographics and AI-led efficiency could reshape preventive healthcare, pointing to a Fair Value of R$19.5, a price implied by assumptions of faster scalability and wider long term margins.

The cautious view saw rising inequality and digital disruption as bigger threats, tied to a Fair Value of R$12.25 and a concern that competitive pressure and government cost controls could squeeze Fleury's profitability.

What The Results Changed For The Fleury Debate

Fleury’s Q2 2026 report showed revenue of R$2,316.654m versus R$2,024.533m in Q2 2025, while net income moved from R$152.299m to R$221.85m and net margin shifted from 7.5% to 9.6%. That pattern gave the optimistic story more support, although one year of higher profitability still does not settle whether these margins can hold through tougher conditions.

The lesson is simple. When a thesis leans on efficiency and pricing power, you stress test it against net margin over several periods, not just revenue growth alone.

What Fleury’s Current Price Already Assumes

Fleury now trades at R$23.5, while the selected Narrative’s Fair Value sits below that level based on its own framework rather than any hard truth about the business.

The Narrative leans on digital platforms, automation and demographics, but worries about contract concentration and Brazil-heavy exposure. Anyone paying today’s price is effectively assuming these investments turn into durable earnings, so the source’s concerns about contract churn and cost pressure become the key variables to test.

"Heavy reliance on large contracts and episodic demand, rising costs, increased competition, and Brazil-centric exposure threaten Fleury's long-term revenue stability, margins, and growth."

One Narrative has put a figure on that disagreement. → See the Narrative with its lower Fair Value, assumptions and all

Go Straight To The Source

You may be late to this rally, but that does not have to mean arriving late to every opportunity. Start with companies whose prices leave room for a different view of their future. Here are three trading below our estimates.

• Company 1 - 26% below our estimate - uses a tech enabled platform to attract senior lawyers seeking higher fee shares and flexibility.
• Company 2 - 23% below our estimate - adds new pharmacies and loyalty perks that turn chronic prescriptions into higher repeat store visits.
• Company 3 - 44% below our estimate - wins long running public works and energy grid projects that bundle construction with recurring technical services.

That is three of the list. See every one of the 208 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com